T-lymphocyte (green) attacking a cancer cell (blue).

The Cancer Immunotherapy Trials Network, CITN, employs the collective expertise of top academic immunologists to design and conduct cancer therapy trials with the most promising immunotherapy agents prioritized for high potential in treating cancer,  in collaboration with National Cancer Institute, foundation and industry partners.

Our Vision is to facilitate broad availability of immunotherapy agents, with known and proven biologic function, for treating cancer patients.

Fred Hutchinson Cancer Research Center UW Medicine